BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 4330088)

  • 1. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 .
    Boullin DJ; Green AR; Price KS
    J Physiol; 1972 Mar; 221(2):415-26. PubMed ID: 5020984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.
    Marquis NR; Vigdahl RL; Tavormina PA
    Biochem Biophys Res Commun; 1969 Sep; 36(6):965-72. PubMed ID: 4310150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
    Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
    Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by isochinoline derivatives.
    Markwardt F
    Acta Univ Carol Med Monogr; 1972; 52():79-82. PubMed ID: 4361263
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of dipyridamole-like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets.
    Söderbäck U; Sollevi A
    Thromb Res; 1991 Nov; 64(3):355-62. PubMed ID: 1666697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.
    Rozenberg MC; Walker CM
    Br J Haematol; 1973 Apr; 24(4):409-18. PubMed ID: 4351761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vasodilators.
    Vigdahl RL; Mongin J; Marquis NR
    Biochem Biophys Res Commun; 1971 Mar; 42(6):1088-94. PubMed ID: 4323846
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M; Zahavi J; Kakkar VV
    Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of cyclic nucleotide phosphodiesterases inhibit protein carboxyl methylation in intact blood platelets.
    Macfarlane DE
    J Biol Chem; 1984 Jan; 259(2):1357-62. PubMed ID: 6198323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
    Asano T; Ochiai Y; Hidaka H
    Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.
    Vigdahl RL; Marquis NR; Tavormina PA
    Biochem Biophys Res Commun; 1969 Oct; 37(3):409-15. PubMed ID: 4310667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.